Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses
Authors:
Open Access
- 23 October 2025
- journal article
- research article
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 11 (1) , 1-14
Abstract
The risk of developing Parkinson’s disease (PD) is elevated in individuals with type 2 diabetes (T2DM), but the molecular pathways underlying this link remain unclear. Glycation, a non-enzymatic modification of lysine and arginine residues by reducing sugars or reactive dicarbonyls, may disrupt proteostasis and trigger pathology. Here, we investigated how methylglyoxal (MGO)- and ribose-mediated glycation influence aSyn aggregation, neuroinflammation, and detoxification pathways. Using SH-SY5Y cells, primary neurons, primary microglia and MGO-injected aSyn transgenic mice, we found that MGO-glycated aSyn promotes PD associated pathological features, including pS129-positive aSyn aggregates, neuroinflammation, and impairment of the glyoxalase detoxification pathway. Ribose-glycated aSyn, while immunogenic, exerts limited effects on aggregation and seeding. Both glycated species activates microglia and upregulate pro-inflammatory markers. We further developed a novel antibody specific for MGO-glycated aSyn, which selectively detects Lewy body–like deposits in dementia with Lewy bodies (DLB) tissue and MGO-injected mice. These findings implicate MGO-glycation in PD-T2DM comorbidity.Keywords
All Related Versions
Funding Information
- Michael J Fox Foundation (EXC 2067/1-390729940)
- Michael J Fox Foundation (EXC 2067/1-390729940)
- Alzheimer’s Research UK Senior Fellowship (ARUK-SRF2022A-006)
This publication has 92 references indexed in Scilit:
- Glycation of α-synuclein hampers its binding to synaptic-like vesicles and its driving effect on their fusionCellular and Molecular Life Sciences, 2022
- Association between diabetes mellitus and risk of Parkinson's disease: A prisma‐compliant meta‐analysisBrain and Behavior, 2021
- Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and ProgressionMovement Disorders, 2021
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?Diabetologia, 2012
- Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stressCellular and Molecular Life Sciences, 2010
- Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) studyDiabetologia, 2010
- Advanced glycation end products induce in vitro cross‐linking of α‐synuclein and accelerate the process of intracellular inclusion body formationJournal of Neuroscience Research, 2008
- Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promotersJournal of Neuroscience Research, 2002
- Alterations in the distribution of glutathione in the substantia nigra in Parkinson's diseaseJournal of Neural Transmission, 1997